Researchers will discuss how to age with a high quality of life during the Comprehensive Center for Healthy Aging 2018 Symposium on April 26.
This microRNA is a biomarker for bronchopulmonary dysplasia, a disease that can lead to death or long-term disease in extremely low birth-weight infants.
nycu graphic 2Physicians at UAB share tips on men’s health and how it affects heart health, sexual function and memory and decreases cancer risk.
ECMO and autoantibody reduction through plasma exchange, experimental therapies not available everywhere, help end an Alabama woman’s five-month medical ordeal.
A two-drug combination therapy for cystic fibrosis is shown to be effective. Triple combination therapy is close behind.
Do you know the warning signs of sepsis? Most Americans don’t … and they should.
A new UAB study will investigate the role of autoantibodies and the benefit of therapeutic plasma exchange on a deadly lung disease.
A UAB physician will co-chair a steering committee of global cystic fibrosis experts and clinical trial investigators to support the design, conduct and execution of the triple combination pivotal study program.
Successful Phase III trials at UAB contributed to the development of a novel “corrector-potentiator” combination drug therapy for cystic fibrosis patients.
As lung diseases worsen worldwide, UAB has launched a pre-doctoral training program in pulmonary research that will focus on lung diseases such as asthma, cancer, COPD, cystic fibrosis, pneumonia, lung injury and idiopathic pulmonary fibrosis.
UAB’s Jack Hasson has been named the 2017 Outstanding Clinician by the American Thoracic Society.
Three UAB investigators have received innovative research grants for lung diseases from the National Institutes of Health.
UAB’s Mark Dransfield has been elected to the American Society for Clinical Investigation, an honor society for physician-scientists who have made significant contributions to better understanding of human disease.
UAB has created the only comprehensive interventional pulmonary medicine program in Alabama to better diagnose and treat lung and chest diseases.
In another example of precision medicine, UAB researchers have used IPF patients own lung tissue to create models to determine the most effective medication for that patient.
A new national, multisite study, chaired by a UAB pulmonologist, shows that supplemental oxygen does not reduce mortality or hospitalization for COPD patients with moderately low levels of blood oxygen.

Exacerbations of COPD, particularly mild COPD, lead to a decline in lung function in smokers, according to new research from UAB.

Ben Branscomb, a pioneering physician and long-time UAB faculty member, was often called the father of pulmonary medicine.
Michelle Harris came to UAB on maximal life support, unsure if she would live after a rare multisystem autoimmune disease attacked her lungs. Now, she will go home with her eyes on upcoming prom and graduation.
UAB launches new clinic for primary ciliary dyskinesia, a rare, inherited respiratory disease.
Page 1 of 3
Back to Top